2017
DOI: 10.3174/ajnr.a5301
|View full text |Cite
|
Sign up to set email alerts
|

Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging

Abstract: BACKGROUND AND PURPOSE: Prognosis in glioma depends strongly on tumor grade and proliferation. In this prospective study of patients with untreated primary cerebral gliomas, we investigated whether amide proton transfer-weighted imaging could reveal tumor proliferation and reliably distinguish low-grade from high-grade gliomas compared with Ki-67 expression and proton MR spectroscopy imaging.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
46
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(52 citation statements)
references
References 27 publications
3
46
2
Order By: Relevance
“…On the other hand, in patients with pathologically confirmed low‐grade gliomas, including those with gadolinium enhancement, APTw imaging shows isointensity or scattered punctate hyperintensity within the lesion. These initial findings, confirmed by different researchers, indicate that APTw imaging for malignant brain tumors has the unique potential to become a valuable imaging biomarker for separating high‐ from low‐grade gliomas and to detect high‐grade tumors that do not show gadolinium enhancement or false‐positive low‐grade tumors that enhance.…”
Section: Current Applicationsmentioning
confidence: 73%
See 1 more Smart Citation
“…On the other hand, in patients with pathologically confirmed low‐grade gliomas, including those with gadolinium enhancement, APTw imaging shows isointensity or scattered punctate hyperintensity within the lesion. These initial findings, confirmed by different researchers, indicate that APTw imaging for malignant brain tumors has the unique potential to become a valuable imaging biomarker for separating high‐ from low‐grade gliomas and to detect high‐grade tumors that do not show gadolinium enhancement or false‐positive low‐grade tumors that enhance.…”
Section: Current Applicationsmentioning
confidence: 73%
“…GRADING TUMORS. The early clinical results on 3 T clinical MRI scanners from several labs 23,[81][82][83][84][85][86][87][88] show that APTw hyperintensity (either ring-like or nodular) is a typical feature of high-grade gliomas (grades III and IV). Gadoliniumenhanced MRI is limited in that some high-grade gliomas (roughly 10% of glioblastomas and 30% of anaplastic astrocytomas 89 ) demonstrate no gadolinium enhancement.…”
Section: Current Applicationsmentioning
confidence: 99%
“…In our present study, the results presented that the signal intensity was significantly different between the WHO II, III and IV gliomas, which were also consistent with the results of previous studies. [10,12]…”
Section: Discussionmentioning
confidence: 99%
“…This correlates with APTw intensity values and thus APTw imaging can be used for tumor characterization and diagnosis (Togao et al, 2014; Jiang et al, 2016, 2017a,b, 2019; Ma et al, 2016; Park et al, 2016; Su et al, 2017; Yu et al, 2017; Dreher et al, 2018, 2019; Van de Ven and Keupp, 2018; Zhou et al, 2019). Hence APTw imaging allows the differentiation of low-grade gliomas from high grade gliomas (Jiang et al, 2017a; Su et al, 2017; Van de Ven and Keupp, 2018), the prediction of the isocitrate dehydrogenase (IDH) mutation status in gliomas (Jiang et al, 2017b; Dreher et al, 2018), the differentiation of high grade gliomas from primary central nervous system lymphomas (Jiang et al, 2016) and from metastases (Yu et al, 2017) and the differentiation of tumor progression and treatment effects (Ma et al, 2016; Van de Ven and Keupp, 2018; Jiang et al, 2019). The technique has also been applied for the non-invasive detection of intracranial hemorrhage in various stages of blood degradation in acute, subacute and chronic stages (Ma et al, 2017) and of acute ischemic cerebral strokes (Park et al, 2016; Zhou et al, 2019).…”
Section: Introductionmentioning
confidence: 89%